LQDA Liquidia Corporation
Liquidia Corporation (LQDA) is expected to report earnings on November 11, 2026, before the market open. The consensus earnings estimate is $0.82 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -17.9% since its last earnings release on August 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company. It develops, manufactures and commercializes products for unmet patient needs principally in the United States. Liquidia Corporation, formerly known as LIQUIDIA TECHNL, is based in Morrisville, North Carolina.
Sector
Healthcare
Industry
Biotechnology